Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

David L. Kreitzman, MD, PC, Commack

Albany Medical College, Albany

Neurology/Neurophysiology, Johnstown

Asheville Neurology Specialists, PA, Asheville

Tallahassee Neurological Clinic, P.A., Tallahassee

University of Florida, Gainesville

Infinity Clinical Research, LLC, Sunrise

Parkinson's Disease and Movement Disorder Center of Boca Raton, Boca Raton

Parkinson's Disease Treatment Center of SW Florida, Port Charlotte

SRI Biosciences, Clinical Trials and Strategic Development Services, Plymouth

Washington University School of medicine, St Louis

CNS Network, Torrance

SC3 Research-Reseda, Pasadena

SC3 Research-Reseda, Reseda

The Neurology Group, Pomona

ATP Clinical Research, Inc., Costa Mesa

The Parkinson's and Movement Disorder Institute, Fountain Valley

Booth Gardner Parkinson's Care Center, Kirkland

Inland Northwest Research, Spokane

Associated Neurologists, P.C., Danbury

Bio Behavioral Health, Toms River